Ad blocking detected

Thank you for visiting CanadianInsider.com. We have detected you cannot see ads being served on our site due to blocking. Unfortunately, due to the high cost of data, we cannot serve the requested page without the accompanied ads.

If you have installed ad-blocking software, please disable it (sometimes a complete uninstall is necessary). Private browsing Firefox users should be able to disable tracking protection while visiting our website. Visit Mozilla support for more information. If you do not believe you have any ad-blocking software on your browser, you may want to try another browser, computer or internet service provider. Alternatively, you may consider the following if you want an ad-free experience.

Canadian Insider Ultra Club
$432/ year*
Daily Morning INK newsletter
+3 months archive
Canadian Market INK weekly newsletter
+3 months archive
30 publication downloads per month from the PDF store
Top 20 Gold, Top 30 Energy, Top 40 Stock downloads from the PDF store
All benefits of basic registration
No 3rd party display ads
JOIN THE CLUB

* Price is subject to applicable taxes.

Paid subscriptions and memberships are auto-renewing unless cancelled (easily done via the Account Settings Membership Status page after logging in). Once cancelled, a subscription or membership will terminate at the end of the current term.

Globe Newswire News Releases

Jun 17, 2024 08:35 ET
Gemina Labs to Present at the Life Science Investor Forum June 20th
Gemina Laboratories Ltd (CSE:GLAB) based in Burnaby focused on diagnostic technologies for Point of Care Diagnostics today announced that Brian Firth CEO and Rob Greene CTO will present live at the Life Science Investor Forum with Virtual Investor...
Jun 17, 2024 08:35 ET
Triumph Financial and C.H. Robinson Announce Strategic Relationship
Triumph Financial, Inc. (Nasdaq: TFIN) and global logistics provider C.H. Robinson (Nasdaq: CHRW) announced today a strategic relationship focused on delivering innovative payment solutions to the transportation industry. C.H. Robinson will join...
Jun 17, 2024 08:32 ET
Rothamsted Research Grants Yield10 Bioscience an Exclusive, Global Commercial License to Advanced Technology for Producing Omega-3 Products in Camelina
Yield10 Bioscience, Inc. (OTC:YTEN) (“Yield10” or the “Company”), an agricultural bioscience company, today announced that U.K.-based Rothamsted Research Limited (“Rothamsted”) has granted to the Company an exclusive global, commercial license to...
Jun 17, 2024 08:32 ET
Aerovate Therapeutics Announces 24-Week Topline Results from the Phase 2b Portion of IMPAHCT Evaluating AV-101 for the Treatment of Pulmonary Arterial Hypertension
Aerovate Therapeutics, Inc. (Nasdaq: AVTE) today announced topline results from the Phase 2b portion of the Inhaled iMatinib Pulmonary Arterial Hypertension Clinical Trial (IMPAHCT), a Phase 2b/Phase 3, randomized, double-blind, placebo-controlled,...
Jun 17, 2024 08:30 ET
P10 Announces Results of its Annual Meeting of Stockholders
P10, Inc. (NYSE: PX) (the “Company”), a leading private markets solutions provider, announced the voting results of its Annual Meeting of Stockholders. All motions put forward by the Company were passed. Additionally, the Board of Directors (the...
Jun 17, 2024 08:30 ET
Mustang Bio Announces Favorable Efficacy and Safety Data from Complete Waldenstrom Macroglobulinemia Cohort of Phase 1/2 Clinical Trial of MB-106, CD20-Targeted Autologous CAR-T Therapy
Mustang Bio, Inc. (“Mustang” or the “Company”) (Nasdaq: MBIO), a clinical-stage biopharmaceutical company focused on translating today’s medical breakthroughs in cell therapies into potential cures for difficult-to-treat cancers, today announced...
Jun 17, 2024 08:30 ET
Orrstown Financial Services, Inc. and Codorus Valley Bancorp, Inc. Announce Receipt of Regulatory Approvals for Merger of Equals
Orrstown Financial Services, Inc. (“Orrstown”) (NASDAQ: ORRF), the parent company of Orrstown Bank, and Codorus Valley Bancorp, Inc. (“Codorus Valley”) (NASDAQ: CVLY), the parent company of PeoplesBank, A Codorus Valley Company, today announced...
Jun 17, 2024 08:30 ET
Evoke Pharma Reports Commercial Strategy Progress & Positive Momentum for GIMOTI
Evoke Pharma, Inc. (NASDAQ: EVOK), a specialty pharmaceutical company focused primarily on treatments for gastrointestinal (GI) diseases with an emphasis on GIMOTI® (metoclopramide) nasal spray, announced updates regarding their business and...
Jun 17, 2024 08:30 ET
Aprea Therapeutics Announces First Patient Dosed in ACESOT-1051 Phase 1 Trial Evaluating Oral WEE1 Inhibitor APR-1051
Aprea Therapeutics, Inc. (Nasdaq: APRE) (“Aprea”, or the “Company”), a clinical-stage biopharmaceutical company focused on precision oncology through synthetic lethality, today announced that the first patient has been dosed in the ACESOT-1051...
Jun 17, 2024 08:30 ET
Atossa Set to Join Russell 3000® Index Effective June 28, 2024
Atossa Therapeutics, Inc. (Nasdaq: ATOS) (“Atossa” or the “Company”), today announced its expected upcoming inclusion in the Russell 3000® Index, according to preliminary Russell reconstruction information posted on the FTSE Russell website. The...
Jun 17, 2024 08:30 ET
Butler Hall Capital LLC has issued an open letter to VNDA’s board of directors urging the company to run a full sales process to maximize shareholder value
Butler Hall Capital LLC has issued a 2nd letter to the board of directors (the “Board”) of Vanda Pharmaceuticals Inc. (“Vanda” or the “Company”), urging the Board to immediately form an independent special committee to run a full sales process to...
Jun 17, 2024 08:30 ET
Chijet Motor Company, Inc.’s Subsidiary Signed Cooperation Agreement with the Auto Dealer of Algeria
Chijet Motor Company, Inc. (Nasdaq: CJET) (the “Company” or “Chijet”), a high-tech enterprise engaged in the development, manufacture, sales, and service of traditional fuel vehicles and new energy vehicles (“NEV”) in China announced that on May...
Jun 17, 2024 08:30 ET
FDA Approves Phase II Clinical Trial for Ruxoprubart in ANCA Associated Vasculitis (AAV) – a Chronic Rare Disease in Nephrology
Associated Vasculitis (AAV) Patients A Phase II, Efficacy Trial in adult AAV patients has been approved by the FDA. Ruxoprubart is a first-in-class treatment for sustaining remission in AAV patients as a conjunctive therapy along with Standard of...
Jun 17, 2024 08:30 ET
First Western Financial, Inc. Announces Stock Repurchase Program
First Western Financial, Inc. (NASDAQ: MYFW), a financial services holding company headquartered in Denver, Colorado (“First Western” or “the Company”), announced that on June 13, 2024 its Board of Directors approved a stock repurchase program that...
Jun 17, 2024 08:30 ET
Freddie Mac Multifamily to Offer Social Bonds Issuance Supporting Housing for Individuals with Intellectual and Developmental Disabilities
Freddie Mac (OTCQB: FMCC) Multifamily today announced that it will soon go to market with the issuance of $186 million in Social Bonds supporting 641 rental homes for individuals with intellectual and developmental disabilities across 26 states....
Jun 17, 2024 08:30 ET
GigaCloud Technology Inc’s Founder, Chairman, and CEO Larry Wu Named Entrepreneur Of The Year® 2024 Greater Los Angeles Award Winner
GigaCloud Technology Inc (Nasdaq: GCT) (“GigaCloud” or the “Company”), a pioneer of global end-to-end B2B technology solutions for large parcel merchandise, today announced that its Founder, Chairman, and Chief Executive Officer, Larry Wu, has been...
Jun 17, 2024 08:30 ET
Goodness Growth Holdings Announces Closing of Recently Announced Non-Brokered Private Placement
Goodness Growth Holdings, Inc. ("Goodness Growth" or the "Company") (CSE: GDNS; OTCQX: GDNSF), a cannabis company committed to providing safe access, quality products and great value to its customers, today announced that it completed the...
Jun 17, 2024 08:30 ET
Jon Wilk Named Visionary CEO at Banking Tech Awards
CompoSecure, Inc. (Nasdaq: CMPO), a leader in metal payment cards, security, and authentication solutions, today announced CEO Jon Wilk won the Tech Leadership Award for Visionary CEO from the Banking Tech Awards USA. Winners were announced at a...
Jun 17, 2024 08:30 ET
Kiniksa Pharmaceuticals Sponsors American Heart Association’s Addressing Recurrent Pericarditis Initiative
Kiniksa Pharmaceuticals, Ltd. (Nasdaq: KNSA) (Kiniksa), a commercial-stage biopharmaceutical company with a pipeline of immune-modulating assets designed to target a spectrum of cardiovascular and autoimmune diseases, today announced its...
Jun 17, 2024 08:30 ET
Microbot Medical Announces Brigham and Women's Hospital as a Site for its Pivotal Human Clinical Trial
Microbot Medical Inc. (Nasdaq: MBOT) today announces that Brigham and Women’s Hospital (BWH), a leading academic medical center located in Boston, Massachusetts, will participate as a clinical trial site for the pivotal human clinical trial as part...